Related references
Note: Only part of the references are listed.A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2021)
Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis
Chuiwen Deng et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multi-omits: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases
Heekyong R. Bae et al.
JOURNAL OF AUTOIMMUNITY (2020)
Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial
Amardeep Khanna et al.
HEPATOLOGY (2019)
Obeticholic acid in primary biliary cholangitis: where we stand
Vignan Manne et al.
CURRENT OPINION IN GASTROENTEROLOGY (2019)
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
Akira Honda et al.
HEPATOLOGY (2019)
The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis
Hussien Al-Shamma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial
George Dalekos et al.
JOURNAL OF HEPATOLOGY (2019)
Effects of Age and Sex of Response to Ursodeoxycholic Arid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
Angela C. Cheung et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
Michael Trauner et al.
HEPATOLOGY (2019)
Dual PPAR/agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
Mukul R. Jain et al.
LIVER INTERNATIONAL (2018)
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Mei Lu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era Role of Scoring Systems
Aparna Goel et al.
CLINICS IN LIVER DISEASE (2018)
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V. Kowdley et al.
HEPATOLOGY (2018)
Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study
C. Schramm et al.
JOURNAL OF HEPATOLOGY (2018)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model o f nonalcoholic steatohepatitis
Ying-Bin Hu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Fan Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
Samer Al-Dury et al.
FRONTIERS IN PHARMACOLOGY (2018)
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Isabel Fabregat et al.
FRONTIERS IN ONCOLOGY (2018)
Gut microbiota translocation promotes autoimmune cholangitis
Hong-Di Ma et al.
JOURNAL OF AUTOIMMUNITY (2018)
Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20-and FcγR-Expressing Mice
Yuki Moritoki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Marco Carbone et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Molecular Magnetic Resonance Imaging Accurately Measures the Antifibrotic Effect of EDP-305 a Novel Farnesoid X Receptor Agonist
Derek J. Erstad et al.
HEPATOLOGY COMMUNICATIONS (2018)
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double Blind Placebo Controlled Trial
Marlyn J. Mayo et al.
HEPATOLOGY COMMUNICATIONS (2018)
Large-Scale Characterization Study of Patients With Antimitochondrial Antibodies but Nonestablished Primary Biliary Cholangitis
Geraldine Dahlqvist et al.
HEPATOLOGY (2017)
Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
Sumeyye Samur et al.
HEPATOLOGY (2017)
Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation
Hong-Di Ma et al.
JOURNAL OF AUTOIMMUNITY (2017)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Interactions between gut bacteria and bile in health and disease
Sarah L. Long et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis
Gloria Alvarez-Sola et al.
DIGESTIVE DISEASES (2017)
Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function
Qian Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach
Hani S. Mousa et al.
AUTOIMMUNITY REVIEWS (2016)
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score
Vinod S. Hegade et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Chronic Expression of Interferon-Gamma Leads to Murine Autoimmune Cholangitis With a Female Predominance
Heekyong R. Bae et al.
HEPATOLOGY (2016)
Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human Cholangiocytes
Jung-Chin Chang et al.
HEPATOLOGY (2016)
Bile Acids as Hormones: The FXR-FGF15/19 Pathway
Steven A. Kliewer et al.
DIGESTIVE DISEASES (2015)
Natural Killer Cells Regulate T Cell Immune Responses in Primary Biliary Cirrhosis
Shinji Shimoda et al.
HEPATOLOGY (2015)
Fibrates and cholestasis
Nisanne S. Ghonem et al.
HEPATOLOGY (2015)
Primary biliary cirrhosis
Elizabeth J. Carey et al.
LANCET (2015)
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
Chemokine-Chemokine Receptor CCL2-CCR2 and CX3CL1-CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis
Motoko Sasaki et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice
Deborah L. Hodge et al.
JOURNAL OF AUTOIMMUNITY (2014)
Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study
Kirsten Boonstra et al.
LIVER INTERNATIONAL (2014)
Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate
Silke Kleinboelting et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with UDCA-Resistant Primary Biliary Cirrhosis
Li Wang et al.
STEM CELLS AND DEVELOPMENT (2014)
Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance
Satoshi Yamagiwa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid
Robert P. Myers et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis
Gideon M. Hirschfield et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Clinicopathological Significance of Serum Fractalkine in Primary Biliary Cirrhosis
Kenichi Harada et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis
Lifeng Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
Joy X. Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
Elaine Studer et al.
HEPATOLOGY (2012)
Liver X Receptor β and Peroxisome Proliferator-Activated Receptor δ Regulate Cholesterol Transport in Murine Cholangiocytes
Xuefeng Xia et al.
HEPATOLOGY (2012)
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
Masanobu Tsuda et al.
HEPATOLOGY (2012)
Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
Magd A. Kotb
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Kirsten Boonstra et al.
JOURNAL OF HEPATOLOGY (2012)
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
C. Levy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis
Y. M. Ambrosini et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model
Dandan Wang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2011)
Innate Immunity and Primary Biliary Cirrhosis: Activated Invariant Natural Killer T Cells Exacerbate Murine Autoimmune Cholangitis and Fibrosis
Si-Jie Wu et al.
HEPATOLOGY (2011)
The role of the innate immune recognition systemin the pathogenesis of primary biliary cirrhosis: a conceptual view
Peter A. Berg
LIVER INTERNATIONAL (2011)
CX3CL1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis
Shinji Shimoda et al.
HEPATOLOGY (2010)
Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis
Ana Lleo et al.
HEPATOLOGY (2010)
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Jane Hoyt Buckner
NATURE REVIEWS IMMUNOLOGY (2010)
Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population
G. Rong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Innate Immunity and Primary Biliary Cirrhosis
Carlo Selmi et al.
CURRENT MOLECULAR MEDICINE (2009)
Ae2a,b-Deficient mice exhibit osteopetrosis of long bones but not of calvaria
Ineke D. C. Jansen et al.
FASEB JOURNAL (2009)
Deficiency in Regulatory T Cells Results in Development of Antimitochondrial Antibodies and Autoimmune Cholangitis
Weici Zhang et al.
HEPATOLOGY (2009)
Molecular physiology and genetics of Na+-independent SLC4 anion exchangers
Seth L. Alper
JOURNAL OF EXPERIMENTAL BIOLOGY (2009)
Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis
January T. Salas et al.
GASTROENTEROLOGY (2008)
Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice
Guo-Xiang Yang et al.
HEPATOLOGY (2008)
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease
Kanji Wakabayashi et al.
HEPATOLOGY (2008)
CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis
Shinji Shimoda et al.
JOURNAL OF AUTOIMMUNITY (2008)
The anion exchanger Ae2 is required for enamel maturation in mouse teeth
D. M. Lyaruu et al.
MATRIX BIOLOGY (2008)
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
Kazuyoshi Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
M. Eric Gershwin et al.
HEPATOLOGY (2008)
Cholangiocyte biology
Pamela Tietz Bogert et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Interpreting serological tests in diagnosing autolmmune liver diseases
Pietro Invernizzi et al.
SEMINARS IN LIVER DISEASE (2007)
Urban aerosols harbor diverse and dynamic bacterial populations
Eoin L. Brodie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
Minoru Nakamura et al.
HEPATOLOGY (2007)
IL-2 receptor α-/- mice and the development of primary biliary cirrhosis
Kanji Wakabayashi et al.
HEPATOLOGY (2006)
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice
Sabine Oertelt et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis
Christopher A. Aoki et al.
JOURNAL OF AUTOIMMUNITY (2006)
Inefficient chronic activation of parietal cells in Ae2a,b-/- mice
Sergio Recalde et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis
Junichiro Irie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis
RY Lan et al.
HEPATOLOGY (2006)
Interferon γ accelerates NF-κB activation of biliary epithelial cells induced by toll-like receptor and ligand interaction
K Harada et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Medical progress: Primary biliary cirrhosis
MM Kaplan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration
C Okada et al.
LIVER INTERNATIONAL (2005)
Th1 cytokine-induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis
K Harada et al.
HEPATOLOGY (2005)
Cloning and characterization of the human soluble adenylyl cyclase
WD Geng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Recognition of bacterial glycosphingolipids by natural killer T cells
Y Kinjo et al.
NATURE (2005)
Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide
RN Fedorak et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies
PSC Leung et al.
JOURNAL OF IMMUNOLOGY (2003)
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
G Paumgartner et al.
HEPATOLOGY (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Identification of HLA-A2-restricted CD8+ cytotoxic T cell responses in primary biliary cirrhosis:: T cell activation is augmented by immune complexes cross-presented by dendritic cells
H Kita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: Connecting xenobiotics with primary biliary cirrhosis
SA Long et al.
JOURNAL OF IMMUNOLOGY (2001)
Proposal of the genus Sphingomonas sensu stricto and three new genera, Sphingobium, Novosphingobium and Sphingopyxis, on the basis of phylogenetic and chemotaxonomic analyses
M Takeuchi et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2001)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata
K Kawahara et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
